Brompheniramine, codeine, and phenylephrine and Ranibizumab ophthalmic
Determining the interaction of Brompheniramine, codeine, and phenylephrine and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brompheniramine / codeine / phenylephrine
Brand name: M-End PE, Poly-Tussin AC, TL-Hist CD
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brompheniramine, codeine, and phenylephrine-Ranitidine
- Brompheniramine, codeine, and phenylephrine-Ranitidine Capsule
- Brompheniramine, codeine, and phenylephrine-Ranitidine Hydrochloride
- Brompheniramine, codeine, and phenylephrine-Ranitidine Injection
- Brompheniramine, codeine, and phenylephrine-Ranitidine Suspension
- Brompheniramine, codeine, and phenylephrine-Ranitidine Syrup
- Ranibizumab ophthalmic-Brompheniramine, Codeine, and Phenylephrine Liquid
- Ranibizumab ophthalmic-Brompheniramine, codeine, and pseudoephedrine
- Ranibizumab ophthalmic-Brompheniramine, dextromethorphan, and phenylephrine
- Ranibizumab ophthalmic-Brompheniramine, dextromethorphan, and pseudoephedrine
- Ranibizumab ophthalmic-Brompheniramine, dextromethorphan, guaifenesin, and phenylephrine
- Ranibizumab ophthalmic-Brompheniramine, hydrocodone, and pseudoephedrine